L879-0191 Screening compound: N-(1H-1,3-benzodiazol-2-yl)-2-[2-(3,4-diethoxyphenyl)acetamido]-4-methylpentanamide

L879-0191 Screening compound: N-(1H-1,3-benzodiazol-2-yl)-2-[2-(3,4-diethoxyphenyl)acetamido]-4-methylpentanamide
L879-0191 Screening compound: N-(1H-1,3-benzodiazol-2-yl)-2-[2-(3,4-diethoxyphenyl)acetamido]-4-methylpentanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L879-0191
N-(1H-1,3-benzodiazol-2-yl)-2-[2-(3,4-diethoxyphenyl)acetamido]-4-methylpentanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L879-0191

Molecular Formula

C25H32N4O4 (C25 H32 N4 O4)

Compound Name

N-(1H-1,3-benzodiazol-2-yl)-2-[2-(3,4-diethoxyphenyl)acetamido]-4-methylpentanamide

IUPAC name

N-(1H-13-benzodiazol-2-yl)-2-[2-(34-diethoxyphenyl)acetamido]-4-methylpentanamide

SMILES

CCOc(ccc(CC(NC(CC(C)C)C(Nc1nc(cccc2)c2[nH]1)=O)=O)c1)c1OCC

InChI

InChI=1S/C25H32N4O4/c1-5-32-21-12-11-17(14-22(21)33-6-2)15-23(30)26-20(13-16(3)4)24(31)29-25-27-18-9-7-8-10-19(18)28-25/h7-12,14,16,20H,5-6,13,15H2,1-4H3,(H,26,30)(H2,27,28,29,31)/t20-/m0/s1

InChI Key

GDHAPGWCIWPCTF-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD27483928

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

452.55

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.301

Distribution Coefficient, logD

3.301

Water Solubility, LogSw

-3.64

Polar Surface Area

82.277

Acid Dissociation Constant (pKa)

11.16

Base Dissociation Constant (pKb)

2.74

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

40.00

L879-0191 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

Chelators targeting matrix metalloproteinases library (8930 compounds)

Eccentric PPI Library (11937 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Proteases
  • Proteases
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with L879-0191 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L879-0191?
Check Price and Availability of L879-0191, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L879-0191 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L879-0191
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L879-0191
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L879-0191 available by request